This study is currently not recruiting participants.

A Double-Blind Randomized Placebo-Controlled Multicenter Dose-Ranging Study to Evaluate the Efficacy and Safety of PF-04236921 in Subjects with Systemic Lupus Erythematosus

Study Comparing Investigational Medication with Placebo

Not Recruiting
18 years - 75 years
All
Phase N/A
1 Location

Brief description of study.

The purpose of this research study is to compare the effects of PF-04236921 compared with a placebo.

Detailed description of study

The purpose of this research study is to compare the effects of PF-04236921 compared with a placebo.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Lupus
  • Age: 18 years - 75 years
  • Gender: All

The purpose of this study is to compare the effects of an investigational medication with a placebo. A placebo is an inactive substance that looks like the investigational medication but does not contain any medicine.

Participants in this study will receive either the investigational medication or the placebo. The study procedures will involve regular monitoring and assessments to evaluate the effects of the treatment.

  • Who can participate: Individuals aged 18 and older who meet specific health criteria may be eligible to participate.
  • Study details: Participants will be assigned to receive either the investigational medication or a placebo.
Updated on 19 Feb 2024. Study ID: 1206008960

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team